✦ LIBER ✦

Thymosin alpha-1 with peginterferon alfa-2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role?

✍ Scribed by A. Ciancio; P. Andreone; S. Kaiser; A. Mangia; M. Milella; R. Solà; S. Pol; E. Tsianos; A. De Rosa; R. Camerini; R. McBeath; M. Rizzetto

Book ID: 108886660
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 95 KB
Volume: 19
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2011.01524.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peginterferon alfa-2a and ribavirin for

Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response

✍ C. D. Howell; L. S. Jeffers; W. Cassidy; K. R. Reddy; S. Hu; J. S. Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Exploring differences in response to tre

Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3

✍ J. Powis; K. M. Peltekian; S. S. Lee; M. Sherman; V. G. Bain; C. Cooper; M. Kraj 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Factors associated with rapid and early

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

✍ M. Rodriguez-Torres; M. S. Sulkowski; R. T. Chung; F. M. Hamzeh; D. M. Jensen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Placebo-controlled trial of 400 mg amant

Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection

✍ Michael von Wagner; Wolf Peter Hofmann; Gerlinde Teuber; Thomas Berg; Tobias Goe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

The impact of amantadine on virologic response rates of interferon-based treatment of chronic hepatitis C is controversial. The aim of this study was to compare virological response rates in patients with chronic hepatitis C virus (HCV)-1 infection treated with 400 mg amantadine or placebo in combin

Peginterferon alfa-2b plus weight-based

Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response

✍ A. Craxi; S. Koutsounas; P. Ogurtsov; L. Chemello; M. Maticic; J. Torras; M. Dia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

Combination therapy of thymalfasin (thym

Combination therapy of thymalfasin (thymosin-alpha 1) and peginterferon alfa-2a in patients with chronic hepatitis C virus infection who are non-responders to standard treatment

✍ VINOD RUSTGI 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB